Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Injecting twice a day keeps the levels more stable throughout the day
Key Market Segments Product Type Semaglutide Liraglutide Exenatide Dulaglutide Others Route of Administration Parenteral Oral Application Type 2 diabetes mellitus Obesity Others Distribution Channel Hospital pharmacies Online pharmacies Retail pharmacies Drivers Increasing Global Prevalence of Type 2 Diabetes Mellitus and Obesity is Driving the Market The escalating global prevalence of type 2 diabetes mellitus and obesity is a major driver for the GLP-1 Receptor Agonist Market
Importantly, recent reports showed that about 211% of patients with COVID-19 had underlying chronic liver disease (Jothimani et al., 2020) and that abnormal liver function is rather common in the course of the malady
These hormonal changes are real and measurable
doi: 10.1016/j.foodres.2024.115154 170
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
